XTL6001

· Shanghai Xitaili Biomedicine Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XTL6001, covering 2025-10-03 to 2025-10-03. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of XTL6001 Injection in Healthy and Obese Subjects [Phase 1]